Skip to main content

ADVERTISEMENT

treatment adherence

Research Reports
06/05/2023
Emma L. Barber, MD
Allison M. Saiz, MD
Nicole M. Engel-Nitz, PhD
Scott H. Bunner, MPH
Katrine L. Wallace, PhD
Emma L. Barber, MD, and colleagues investigate current and real-world practice patterns for patients receiving maintenance therapy for recurrent ovarian cancer after second-line chemotherapy.
Emma L. Barber, MD, and colleagues investigate current and real-world practice patterns for patients receiving maintenance therapy for recurrent ovarian cancer after second-line chemotherapy.
Emma L. Barber, MD, and...
06/05/2023
Journal of Clinical Pathways
05/05/2016
JCP Editors
Ibrutinib may improve progression-free survival (PFS) for patients with chronic lymphocytic leukemia (CLL) if the full dose is taken on schedule, according to results extracted from clinical trial data and presented...
Ibrutinib may improve progression-free survival (PFS) for patients with chronic lymphocytic leukemia (CLL) if the full dose is taken on schedule, according to results extracted from clinical trial data and presented...
...
05/05/2016
Journal of Clinical Pathways
Research in Review
12/04/2015
JCP Editors
Patients choosing surveillance over aggressive treatment for prostate cancer are not being monitored as closely as they should be, according to a new study published by a team of University of California, Los Angeles...
Patients choosing surveillance over aggressive treatment for prostate cancer are not being monitored as closely as they should be, according to a new study published by a team of University of California, Los Angeles...
...
12/04/2015
Journal of Clinical Pathways